Thymalfasin: Clinical Trials

9 trials of Thymalfasin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 5, Unknown 4

Follow Thymalfasin: new trials by email Literature Review of Thymalfasin trials Research Report on Thymalfasin

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thymosin Alpha-1 for irAE Secondary to ICIs
Thymosin Alpha1, Immunosuppressant - IrAE
Phase 4UnknownJun Wang402023-09-012023-12-20
Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain
Thymosin Alpha1 - Osteoporotic Pain
Phase 4UnknownRenJi Hospital1002020-11-012020-08-26
Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
Thymosin Alpha 1, normal saline - Pancreatitis, Acute Necrotizing
Phase 4CompletedWeiqin Li5082018-03-272021-04-05
Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients
Thymosin Alpha1, Entecavir - Chronic Hepatitis b
Phase 4UnknownWen-hong Zhang2402017-10-252018-02-28
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
thymosin alpha 1, Placebo - Sepsis
Phase 4CompletedSun Yat-sen University202016-03-312019-04-04
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection
curative resection, thymalfasin, nucleoside analog (suggest to use entecavir) - Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
Phase 4UnknownJia Fan3602015-01-012014-11-21
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
entecavir, Thymosin-α - Liver Cirrhosis
Phase 4CompletedBeijing Friendship Hospital822013-06-012018-07-27
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Entecavir, Thymosin-α - Liver Cirrhosis
Phase 4CompletedBeijing Friendship Hospital6062013-06-012018-07-27
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Pegylated Interferon-alpha2a, Thymosin alpha1 & Pegylated Interferon-alpha2a - Chronic Hepatitis B
Phase 4CompletedSeoul National University Hospital522005-12-012011-07-21

Conditions studied

Hepatitis B (2)  ·  Hepatitis B, Chronic (2)  ·  Liver Cirrhosis (2)  ·  Pancreatitis (1)  ·  Pancreatitis, Acute Necrotizing (1)  ·  Sepsis (1)

Sponsors

Beijing Friendship Hospital (2)  ·  Jia Fan (1)  ·  Jun Wang (1)  ·  RenJi Hospital (1)  ·  Seoul National University Hospital (1)  ·  Sun Yat-sen University (1)  ·  Weiqin Li (1)  ·  Wen-hong Zhang (1)

Countries

China (8)  ·  South Korea (1)

Top investigators

Hong You, Doctor (2)  ·  Jun Wang, Professor (1)  ·  Jung H Yoon, M.D. (1)  ·  Ke Lu, M.D. (1)  ·  Li Weiqin, M.D. (1)  ·  Weifeng Yu (1)  ·  Wenhong Zhang, Ph.D (1)  ·  Wu Jianfeng, M. D (1)  ·  Zhou Jing, M.D. (1)

Results publications

PMID 23050812, PMID 23327199, PMID 26094695, PMID 26632544, PMID 28394330, PMID 32817121, PMID 32994239, PMID 33460002, PMID 34408744, PMID 34843068, PMID 35870709, PMID 37007743, PMID 38356344, PMID 39373164